{
    "organizations": [],
    "uuid": "733f838ce4f4ecb55efcbf8c44dddea9e48bf747",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-luye-pharma-group-posts-fy-profit/brief-luye-pharma-group-posts-fy-profit-attributable-of-rmb981-4-million-idUSFWN1R80W3",
    "ord_in_thread": 0,
    "title": "BRIEF-Luye Pharma Group Posts FY Profit Attributable Of RMB981.4 Million​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Luye Pharma Group Ltd:\n* FY REVENUE UP 30.7% TO RMB3,814.8 MILLION * ‍FY PROFIT ATTRIBUTABLE ROSE 10.1% TO RMB981.4 MILLION​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-26T23:36:00.000+03:00",
    "crawled": "2018-03-27T11:57:38.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "luye",
        "pharma",
        "group",
        "ltd",
        "fy",
        "revenue",
        "million",
        "profit",
        "attributable",
        "rose",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}